Log in to save to my catalogue

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murin...

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5990963

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

About this item

Full title

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

Publisher

London: Nature Publishing Group UK

Journal title

Prostate cancer and prostatic diseases, 2018-04, Vol.21 (1), p.126-136

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
Prostate cancer remains the second leading cause of cancer related death in men. Immune check point blocking antibodies have revolutionized treatment of multiple solid tumors, but results in prostate cancer remain marginal. Previous reports have suggested that local therapies, in particular cryoablation might increase tumor immunogeni...

Alternative Titles

Full title

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5990963

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5990963

Other Identifiers

ISSN

1365-7852

E-ISSN

1476-5608

DOI

10.1038/s41391-018-0035-z

How to access this item